01 3Epidiolex/Epidyolex
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 464
2020 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 736
2021 Revenue in Millions : 658
Growth (%) : 12
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 845
2022 Revenue in Millions : 736
Growth (%) : 15
